| Survivin | EHKKHSSGCAFLSVKKQFEGGGGGGFLKLDRERAKNKGGG |
| MAGE-A4 | NYKRCFPVIFGKGGGGGGALAETSYVKVLEHVVRVNARVR |
| Tyrosinase-A2-1 | YMDGTMSQV |
| gp100-A24-1 | VWKTWGQYW |
| MUC1 | TRPAPGSTAPPAHGVTSAPDTRPAPGSTAP |
| WT1(HLA-A2402) | CYTWNQMNL |
| WT1-0201 | RMFPNAPYL |
| WT1-DR | KRYFKLSHLQMHSRKH |
| WT1-A26 | VTFDGTPSY |
| WT1-1101 | AAGSSSSVK |
| WT1-3303 | SDQLKRHQR |
| WT1-35 | WAPVLDFAPPGASAYGSL |
| ACTH (1-10),Human | SYSMEHFRWG |
| ACTH(1-13),Human | SYSMEHFRWGKPV |
| ACTH(1-16),Human | SYSMEHFRWGKPVGKK |
| ACTH(1-17),Human | SYSMEHFRWGKPVGKKR |
| ACTH(1-4) | SYSM |
| Angiotensinogen(1-14),Human | DRVYIHPFHLVIHN |
| Angiotensin II(1-4),Human | DRVY |
| Angiotensin II(4-8),Human | YIHPF |
| [Sar1]-Angiotensin II | Sar-RVYIHPF |
| Allatostatin I | APSGAQRLYGFGL-NH2 |
| Allatostatin II | GDGRLYAFGL-NH2 |
| Angiotensin Converting Enzyme Inhibitor | pE-WPRPQIPP |
| Angiotensin I-Converting Enzyme Inhibitor (Bradykinin Potentiator B) | pE-GLPPRPKIPP |
| Angiotensin I Converting Enzyme Inhibitor (Bradykinin Potentiator C) | pE-GLPPGPPIPP |
| Angiotensin I Converting Enzyme Inhibitor ([Des-Pro2]-Bradykinin) | RPGFSPFR |
| [Des-Asp1]-Angiotensin I, Human | RVYIHPFHL |
| Tetradecapeptide Renin Substrate, Human | DRVYIHPFHLVIHN |
| Handle Region Peptide (HRP),Rat | RILLKKMP-Ger-V |
| Angiotensins And Related Peptides | Ac-GDYSHCSPLRYYPWWKCTYPDPEGGG-NH2 |
| Dermaseptin | ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ |
| HEL (46-61) | NTDGSTDYGILQINSR |
| Ubiquitin(65-76) | STLHLVLRLRGG |
| Apidaecin IB | GNNRPVYIPQPRPPHPRL |
| Drosocin | GKPRPYSPRPTSHPRPIRV |
| OV-1, Sheep | KNLRRIIRKIIHIIKKYG |
| Levitide | pE-GMIGTLTSKRIKQ-NH2 |
| Indolicidin | ILPWKWPWWWRR-NH2 |
| PGLa | GMASKAGAIAGKIAKVALKAL-NH2 |
| Antioxidant peptide A | PHCKRM |
| [Ala 13]-Apelin-13 | QRPRLSHKGPMPA |
| PUMA BH3 | EEQWAREIGAQLRRMADDLNAQYER |
| Phe-Met-Arg-Phe | FMRF |
| 26Rfa, Hypothalamic Peptide, Human | TSGPLGNLAEELNGYSRKKGGFSFRF-NH2 |
| a-Bag Cell Peptide (1-7) | APRLRFY |
| a-Bag Cell Peptide (1-8) | APRLRFYS |
| a-Bag Cell Peptide (1-9) | APRLRFYSL |
| b-Bag Cell Factor | RLRFH |
| Bactenecin, Bovine | RLCRIVVIRVCR (Disulfide bridge: C3-C11) |
| Flagelin22 | QRLSTGSRINSAKDDAAGLQIA |
| Kallikrein Inhibitor | AC-PFRSVQ-NH2 |
| Tuftsin | TKPR |
| Fibrinopeptide B, Human | GLP-GVNDNEEGFFSAR |
| ACTH (Human, 18-39) | RPVKVYPNGAEDESAEAFPLEF |
| ACTH (Human, 1-24) | SYSMEHFRWGKPVGKKRRPVKVYP |
| ACTH Partial | RPVKVYPNGAEDESAEC |
| ACTH (Human) | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
| ACTH (Rat) | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF |
| [D-Arg8]-ACTH (4-10) | MEHFdRWG |
| AGRP (Human, 25-51) | LAPMEGIRRPDQALLPELPGLGLRAPL |
| AGRP (Human, 54-82) | TTAEQAEEDLLQEAQALAEVLDLQDREPR |
| Amylin (Human, 14-24) | NFLVHSSNNFG |
| Amylin (Human, 1-13) | KCNTATCATQRLA |
| Amylin (74-89), Prepro (Human) | NAVEVLKREPLNYLPL |
| Amylin (Rat) | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 |
| Amyloid β (Human, 1-16) | DAEFRHDSGYEVHHQK |
| Angiotensin II (Human) | DRVYIHPF |
| Angiotensin III (Human) | RVYIHPF |
| Angiotensin IV (Human) | VYIHPF |
| [Val5]-Angiotensin I (Bovine) | DRVYVHPFHL |
| [Asn1,Val5]-Angiotensin II | NRVYVHPF |
| Angiotensin (Human, 1-7) | DRVYIHP |
| [Val5]-Angiotensin II | DRVYVHPF |
| [Des-Asp1,Ile8] Angiotensin II | RVYIHPI |
| [Sar1,Ala8]-Angiotensin II | Sar-RVYIHPA |
| Angiotensin I (Human) | DRVYIHPFHL |
| [Sar1,Ile8]-Angiotensin II | Sar-RVYIHPI |
| [Sar1,Thr8]-Angiotensin II | Sar-RVYIHPT |
| [Sar1,Val5,Ala8]-Angiotensin II | Sar-RVYVHPA |
| Angiotensin | DRVYIHPFH |
| [Des-Asp1]-Angiotensin I (Human) | RVYIHPFHL |
| ANP (Human, 1-28) | SLRRSSCFGGRMDRIGAQSGLGCNSFRY |
| [Met(O)12]-ANP (Human, 1-28) | SLRRSSCFGGR-M(O)-DRIGAQSGLGCNSFRY |
| ANP (Human, 5-27) | SSCFGGRMDRIGAQSGLGCNSFR |
| ANP (Human, 5-28) | SSCFGGRMDRIGAQSGLGCNSFRY |
| ANP (Human, 7-28) | CFGGRMDRIGAQSGLGCNSFRY |
| ANP (Rat, 1-28) | SLRRSSCFGGRIDRIGAQSGLGCNSFRY |
| ANP (Rat, 3-28) | RRSSCFGGRIDRIGAQSGLGCNSFRY |
| Des[Gln18,Ser19,Gly20,22,Leu21]-ANP (Rat, 4-23 Amide) | RSSCFGGRIDRIGAC-NH2 |
| ANP (26-55) | NPMYNAVSNADLMDFKNLLDHLEEKMPLED |
| ANP (56-92) | EVVPPQVLSEPNEEAGAALSPLPEVPPWTGEVSPAQR |
| ANP (104-123) | SSDRSALLKSKLRAL LTAPR |
| ANP (Human, 1-28) | SLRRSSCFGGRMDRIGAQSGLGCNSFRY |
| [Met(O)12]-ANP (Human, 1-28) | SLRRSSCFGGR-M(O)-DRIGAQSGLGCNSFRY |
| ANP (Human, 5-27) | SSCFGGRMDRIGAQSGLGCNSFR |
| ANP (Human, 5-28) | SSCFGGRMDRIGAQSGLGCNSFRY |
| ANP (Human, 7-28) | CFGGRMDRIGAQSGLGCNSFRY |
| ANP (Rat, 1-28) | SLRRSSCFGGRIDRIGAQSGLGCNSFRY |
| ANP (Rat, 3-28) | RRSSCFGGRIDRIGAQSGLGCNSFRY |
| Des[Gln18,Ser19,Gly20,22,Leu21]-ANP (Rat, 4-23 Amide) | RSSCFGGRIDRIGAC-NH2 |
| ANP (26-55) | NPMYNAVSNADLMDFKNLLDHLEEKMPLED |
| ANP (56-92) | EVVPPQVLSEPNEEAGAALSPLPEVPPWTGEVSPAQR |
| ANP (104-123) | SSDRSALLKSKLRAL LTAPR |
| Bradykinin Potentiator C | Pyr-GLPPGPPIPP |
| [Des-Arg9]-Bradykinin | RPPGFSPF |
| [Lysyl-Des-Arg9]-Bradykinin | KRPPGFSPF |
| [Des-Arg9,Leu8]-Bradykinin | RPPGFSPL |
| [Des-Pro2]-Bradykinin | RPGFSPFR |
| [Hyp3]-Bradykinin | RP-Hyp-GFSPFR |
| Lysyl-Bradykinin | KRPPGFSPFR |
| Lysyl-[Hyp3]-Bradykinin | KRP-Hyp-GFSPFR |
| Tyrosyl-Bradykinin | YRPPGFSPFR |
| Bradykinin (Human, Bovine, Rat, Mouse) | RPPGFSPFR |
| Bradykinin-Potentiator B | Pyr-GLPPRPKIPP |
| Isoleucyl-Seryl-Bradykinin (Rat) | ISRPPGFSPFR |
| Methionyl-Lysyl-Bradykinin (Human, Bovine) | MKRPPGFSPFR |
| [Tyr8]-Bradykinin | RPPGFSPYR |
| Bradykinin Potentiating Factor SQ20881 | Pyr-WPRPQIPP |
| [Ac-K0,D-Nal7,I8,Des-R9]-Bradykinin | Ac-KRPPGFS-(D-Nal)-I |
| [K0,D-F8,Des-R9]-Bradykinin | KRPPGFSPdF |
| [K0,L8,Des-R9]-Bradykinin | KRPPGFSPL |
| [Sar0,D-F8,Des-R9]-Bradykinin | Sar-RPPGFSPdF |
| CGRP (Human) | ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 |
| CGRP (Human, 8-37) | VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 |
| CGRP (Rat) | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 |
| Calcitonin (Salmon, 8-32) | VLGKLSQELHKLQTYPRTNTGSGTP-NH2 |
| CGRP (Human, 17-37) | SRSGGVVKNNFVPTNVGSKAF-NH2 |
| CGRP (Rat, 30-37) | TNVGSEAF-NH2 |
| CGRP (Rat, 31-37) | NVGSEAF-NH2 |
| CGRP (Rat, 8-37) | VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 |
| [C(Acm2,7)]-CGRP (Human) | AC(Acm)DTATC(Acm)VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 |
| CCK-4 | WMDF-NH2 |
| CCK-8 | DYMGWMDF-NH2 |
| CCK octapeptide (26-33) (Sulfated Form) | D-Y(SO₃H)-MGWMDF-NH2 |
| CCK-33 (Human) | KAPSGRMSIVKNLQNLDPSHRISDRD-Y(SO3H)-MGWMDF-NH2 |
| CCK Flanking Peptide (Non-Sulfated) | SAEEYEYPS |
| [Thr28,Nle31]-Cholecystokinin-33 (25-33) (sulflated) | RDY(SO3H)TGW-Nle-DF-NH2 |
| CRF (Human, Rat) | SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
| CRF (Ovine) | SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2 |
| Tyrosyl-CRF (Human, Rat) | YSEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
| CRF Antagonist [Alpha-Helical CRF(9-41)] | DLTFHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 |
| Palmitoyl Pentapeptide | Pal-KTTKS |
| Tripeptide-3 | GHR |
| Tetrapeptide-1 | LPTV |
| Tetrapeptide-4 | GEPG |
| Acetyl Tetrapeptide-1 | Myr-GEPG |
| Acetyl Tetrapeptide-2 | DKYV |
| Myristoyl Terapeptide-5 | Myr-VPAA |
| Myristoyl Pentapeptide-3 | Myr-KTTKS |
| Hexapeptide-1 | ARHLFW |
| Acetyl Hexapeptide-1 | Ac-ARHLFW |
| Hexapeptide-6 | VEPIPY |
| Palmitoyl Oligopeptide-3 | Pal-VGVAPG |
| Hexapeptide-8 | STKTTK |
| Nonapeptide-1 | VQGEESNDK |
| α-Defensin-1 (Human) | ACYCRIPACIAGERRYGTCIYQGRLWAFCC |
| Endomorphin-1 (Human, Bovine) | YPWF-NH2 |
| Endomorphin-2 (Human, Bovine) | YPFF-NH2 |
| Suc-[Glu9,Ala11,15] Endothelin (8-21) | Suc-DEEAVYFAHLDIIW |
| Endothelin-1 (Human) | CSCSSLMDKECVYFCHLDIIW |
| Endothelin-1 (Human, 1-31) | CSCSSLMDKECVYFCHLDIIWVNTPEHVVPY |
| Endothelin-2 (Human) | CSCSSWLDKECVYFCHLDIIW |
| Endothelin-3 (Human) | CTCFTYKDKECVYYCHLDIIW |
| Big Endothelin-2 (Human, 1-37) | CSCSSWLDKECVYFCHLDIIWVNTPEQTAPYGLGNPP |
| Big Endothelin-3 (Human, 1-41 Amide) | CTCFTYKDKECVYYCHLDIIWINTPEQTVPYGLSNYRGSFR-NH2 |
| VIC (Mouse) | CSCNSWLDKECVYFCHLDIIW |
| Endothelin-1 Prepro (Human, 18-50) | APETAVLGAELSAVGENGGEKPTPSPPWRLRRS |
| Endothelin-1(ET-1) (22-38), Big(Human) | VNTPEHVVPYGLGSPRS |
| [Ala 11,15]-Endothelin-1 (Human, Porcine, Canine, Rat, Mouse, Bovine, 6-21) | LMDKEAVYFAHLDIIW |
| Endothelin-3 (Human, 22-41 Amide) | INTPEQTVPYGLSNYRGSFR-NH2 |
| Endothelin Antagonist, BQ123 | Cyclo(D-Asp-Pro-D-Val-Leu-D-Trp) |
| Enterostatin (Human, Mouse, Rat)(APGPR) | APGPR |
| Enterostatin (Porcine, Canine, Equine)(VPDPR) | VPDPR |
| Enterostatin (VPGPR) | VPGPR |
| RGDS | RGDS |
| GRGDS | GRGDS |
| Fibronectin Precursor | RGDSPASSKP |
| RGES | RGES |
| RFDS | RFDS |
| Heparin-Binding Peptide V | WQPPRARI |
| Fibronectin (1946-1960) | KNNQKSEPLIGRKKT |
| Fibronectin Type III Connecting Segment(1-25) | DELPQLVTLPHPNLHGPEILDVPST |
| GRGDSPK | GRGDSPK |
| GRGDTP | GRGDTP |
| SDGRG | SDGRG |
| GRGD | GRGD |
| YRGDS | YRGDS |
| Cyclo (RGDdFV) | cyclo (RGDdFV) |
| Cyclo (RGDdFK) | cyclo(RGDdFK) |
| Gastrin I (Human) | Pyr-GPWLEEEEEAYGWMDF-NH2 |
| Gastric Inhibitory Polypeptide(GIP) (Human, 1-42 ) | YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
| Gastrin Relesing Peptide (GRP) (Human) | VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 |
| Gastrin Releasing Peptide(GRP) (Porcine) | APVSVGGGTVLAKMYPRGNHWAVGHLM-NH2 |
| Gastrin Releasing Peptide (Porcine, Human, 14-27) | MYPRGNHWAVGHLM-NH2 |
| Big Gastrin I (Human) | Pyr-LGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF-NH2 |
| Gastrin Relesing Peptide(GRP) (Human, 1-16) | VPLPAGGGTVLTKMYP |
| CTFP of Rat Progastrin | SAEEEDQYN |
| Gastrin Little (Rat) | Pyr-RPPMEEEEEAYGWMDF-NH2 |
| Minigastrin | WLEEEEEAYGWMDF-NH2 |
| GLP-1 (Human, 7-37) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
| GLP-1 (Human, 7-36 Amide) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| GLP-2 (Human) | HADGSFSDEMNTILDNLAARDFINWLIQTKITD |
| Glucagon (Human) | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
| Glucagon-Like peptide (1-36) | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| GLP-2 (Human, 126-159) | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR |
| Glucagon (Dogfish, Scyliorhinus Canidula) | HSEGTFTSDYSKYMDNRRAKDFVQWLMNT |
| Glucagon (Human, 22-29) | FVQWLMNT |
| Glicentin-related Polypeptide (Human) | QDTEEKSRSLRSFSASQADPLSDPDQMNED |
| Glucagon-Like Peptide-1 (GLP-1) ((Human, 9-36 Amide) | EGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| Taspoglutide | H-Aib-EGTFTSDVSSYLEGQAAKEFIAWLVK-Aib-R-NH2 |
| Lixisenatide | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 |
| Liraglutide | HAEGTFTSDVSSYLEGQAAK(γ-E(N-(α-hexadecanoyl)))EFIAWLVRGRG |
| GHRF (Human) | YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 |
| GHRF (Mouse) | HVDAIFTTNYRKLLSQLYARKVIQDIMNKQGERIQEQRARLS |
| GHRF (Human, 1-29 Amide) | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| GHRF (Rat) | HADAIFTSSYRRILGQLYARKLLHEIMNRQQGERNQEQRSRFN |
| [Ac-Y1,D-F2]-GHRF (1-29 Amide) | Ac-YdFDAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| [N-Ac-Y1,D-R2]-GHRF (Human, 1-29 Amide) | Ac-YdRDAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| [H1,Ⅰ27]-GHRF (Human, 1-32 Amide) | HADAIFTNSYRKVLGQLSARKLLQDINleSRQQG-NH2 |
| GHRF (Human, 30-44 Amide) | Pyr-QGESNQERGARARL-NH2 |
| GHRP-6 | HdWAWdFK-NH2 |
| Laminin Pentapeptide (Amide) | YIGSR-NH2 |
| Laminin (925-933) | CDPGYIGSR |
| Laminin A chain (2091-2108) | CSRARKQAASIKVAVSADR |
| Liver-Cell Growth Factor | GHK |
| γ-MSH | YVMGHFRWDRFG |
| α-MSH | Ac-SYSMEHFRWGKPV-NH2 |
| MSH-Release Inhibiting Factor | PLG-NH2 |
| [Des-Acetyl]-α-MSH | SYSMEHFRWGKPV-NH2 |
| β-MSH (Human) | AEKKDEGPYRMEHFRWGSPPKD |
| β-MSH (Monkey) | DEGPYRMEHFRWGSPPKD |
| β-MSH (Porcine) | DEGPYKMEHPRWGSPPKD |
| MSH, Gamma 1 | YVMGHFRWDRF-NH2 |
| MSH, Lys-Gamma 1 | KYVMGHFRWDRF-NH2 |
| MSH, Gamma 3 (Human) | YVMGHFRWDRFGRRNGSSSSGVGGAAQ |
| [Nle4, D-Phe7]-α-MSH | Ac-SYS-Nle-EH-dF-RWGKPV-NH2 |
| MT Ⅱ | Ac-Nle-DH-dF-RWK-NH2 |
| SHU 9119 | Ac-Nle-DHD-Nal(2′)-RWL-NH2 (Amide Brige:Asp3-Lys8) |
| HS 014 | Ac-CEH-(D-Nal)-RWGCPPKD-NH2 |
| HS 024 | Ac-C-Nle-RHD-Nal-RWGC-NH2 |
| Cyclic-[Mpr3,Nle4,Arg5,D-Nal7,Cys11-Amide]-α-MSH (3-11) / JKC-366 | Mpr-Nle-RHD-Nal-RWGC-NH2 |
| Neurokinin A | HKTDSFVGLM-NH2 |
| Neurokinin B | DMHDFFVGLM-NH2 |
| [P7]-Neurokinin B | DMHDFFPGLM-NH2 |
| [D-P2, D-W6, 8, Nle10]-Neurokinin B (Porcine) | DdPHDFdWVdWL-Nle-NH2 |
| (4-10)[Tyr5,D-Trp6,8,9,Arg10]-Neurokinin A (MEN 10 207) | DYdWVdWdWR-NH2 |
| Neurotensin (Human, Bovine, Canine) | Pyr-LYENKPRRPYIL |
| Neurotensin (8-13) | RRPYIL |
| Neurotensin (8-13, Acetyl) | Ac-RRPYIL |
| [Lys8, Asn9]-Neurotensin (8-13) (LANT-6) | KNPYIL |
| Orexin B (Human) | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
| Orexin-B (Rat, Mouse) | RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2 |
| Orexin B (Mouse, Rat, 3-28) | GPPGLQGRLQRLLQANGNHAAGILTM-NH2 |
| Orexin A (Human, Mouse, Rat, 16-33 Amide) | LYELLHGAGNHAAGILTL-NH2 |
| Orexin B (Human, 6-28) | GLQGRLQRLLQASGNHAAGILTM-NH2 |
| [Ala11,D-Leu15]-Orexin B (Human) | RSGPPGLQGRAQRL(dL)QASGNHAAGILTM-NH2 |
| PACAP 27 (Huaman, 1-27 Amide) | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 |
| PACAP38 (Human) | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP (Human, Ovine, Rat, 6-27) | FTDSYSRYRKQMAVKKYLAAVL-NH2 |
| PACAP (Human, Ovine, Rat, 6-38) | FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP-Related Peptide (PRP) (Rat, 12-29) | RKVLDQLSARKYLQSMVA |
| PACAP38 (Human, Ovine, Rat, 31-38) | YKQRVKNK-NH2 |
| PACAP-Related Peptide (PRP) (Human) | DVAHGILNEAYRKVLDQLSAGKHLQSLVA |
| Pancreatic Polypeptide (PPP) (Human) | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 |
| Pancreatic Polypeptide (PPP) (Rat) | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 |
| Peptide YY (Human, 3-36) | IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
| Peptide YY (Human) | YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
| Peptide YY (PYY) (Porcine, Rat) | YPAKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY-NH2 |
| Peptide YY (PYY) (Porcine, Rat, 13-36) | SPEELSRYYASLRHYLNLVTRQRY-NH2 |
| Oxyntomodulin JP10-260 | HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIA |
| Prolactin releasing hormone (Rat) | SRAHQHSMETRTPDINPAWYTGRGIRPVGRF-NH2 |
| Prolactin-Releasing Peptide-31 (PrRP-31) (Human) | SRTHRHSMEIRTPDINPAWYASRGIRPVGRF-NH2 |
| Prolactin-Releasing Peptide-20 (PrRP-20) (Human) | TPDINPAWYASRGIRPVGRF-NH2 |
| Prolactin-Releasing Peptide-20 (PrRP-20) (Rat) | TPDINPAWYTGRGIRPVGRF-NH2 |
| Prolactin-Releasing Peptide-31 (PrRP-31 ) (Bovine) | SRAHQHSMEIRTPDINPAWYAGRGIRPVGRF-NH2 |
| Prolactin-Releasing Peptide-20 (PrRP-20) (Bovine) | TPDINPAWYAGRGIRPVGRF-NH2 |
| Secretin (Human) | HSDGTFTSELSRLREGARLQRLLQGLV-NH2 |
| Secretin (Porcine) | HSDGTFTSELSRLRDSARLQRLLQGLV-NH2 |
| Secretin (Mouse) | HSDGMFTSELSRLQDSARLQRLLQGLV-NH2 |
| Secretin (Rat) | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 |
| Secretin (Canine) | HSDGTFTSELSRLRESARLQRLLQGLV-NH2 |
| [D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P | dRdPKPQQdWFdWLL-NH2 |
| [D-Arg1,D-Trp7,9,Leu11]-Substance P | dRPKPQQdWFdWLL-NH2 |
| [D-Pro2,D-Trp7,9]-Substance P | RdPKPQQdWFdWLM-NH2 |
| Substance P (Human, Bovine, Rat, Mouse) | RPKPQQFFGLM-NH2 |
| [D-Pro4,D-Trp7,9]-Substance P (4-11) | dPQQdWFdWLM-NH2 |
| [Tyr8]-Substance P | RPKPQQFYGLM-NH2 |
| [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | dRPKPdFQdWFdWLL-NH2 |
| Ac-[Arg6,Sar9,Met(O2),11]-Substance P (Human, Rat, Mouse, 6-11) | Ac-RFF-Sar-LM(O2)-NH2 |
| Urotensin II (Human) | ETPDCFWKYCV |
| Urotensin II (Rat) | Pyr-HGTAPECFWKYCI |
| UrotensinⅠ(catostomus commersoni) | NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 |
| Adipokinetic Hormone (AKH)(Locust) | Pyr-LNFTPNWGT-NH2 |
| Adipokinetic Hormone (Heliothis zea and Manduca sexta) | Pyr-LTFTSSWG-NH2 |
| Adipokinetic Hormone II | Pyr-LNFSTGW-NH2 |
| Tabanus atratus Adipokinetic Hormone (Taa-AKH) | Pyr-LTFTPGW-NH2 |
| Adipokinetic Hormone G (AKH-G) (Gryllus bimaculatus) | Pyr-VNFSTGW-NH2 |
| Hypothetical Protein XP_294524 (Human, 190-196 Amide) / P52 / QRFP-7 | GGFSFRF-NH2 |
| Proadrenomedullin (PAMP) (Human) | ARLDVASEFRKKWNKWALSR-NH2 |
| Proadrenomedullin (PAMP) (Rat) | ARLDTSSQFRKKWNKWALSR-NH2 |
| Proadrenomedullin-12 (PAMP-12) (Human) | FRKKWNKWALSR-NH2 |
| Adrenomedullin (Human, 1-25) | YRQSMNNFQGLRSFGCRFGTCTVQK |
| Adrenomedullin (Human, 1-12) | YRQSMNNFQGLR |
| Adrenomedullin (Human, 13-52) | SFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
| Adrenomedullin (Human, 22-52) | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
| Adrenomedullin (Human, 16-52) | CRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
| Adrenomedullin (Human, 34-52) | TDKDKDNVAPRSKISPQGY-NH2 |
| Adrenomedullin (PAMP-20) (Mouse) | AGPDTPSQFRKKWNKWALSR-NH2 |
| Adrenomedullin (Rat, 24-50) | LAHQIYQFTDKDKDGMAPRNKISPQGY-NH2 |
| Adrenomedullin (PAMP-20) (Porcine) | ARLDVAAEFRKKWNKWALSR-NH2 |
| Adrenomedullin (Porcine, 26-52) | LAHQIYQFTDKDKDGVAPRSKISPQGY-NH2 |
| Adrenomedullin (Porcine, 34-52) | TDKDKDGVAPRSKISPQGY-NH2 |
| Allatostatin 3 | GGSLYSFGL-NH2 |
| Allatostatin 4 | DRLYSFGL-NH2 |
| β-Sheet Breaker Peptide IAβ5 | LPFFD |
| β-Aamyloid Partial (3-16) | Pyr-FRHDSGYEVHHQK |
| Amyloid beta (Human, 1-40) | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Amyloid beta(Human, 25-35) | GSNKGAIIGLM |
| Humanin | MAPRGFSCLLLLTSEIDLPVKRRA |
| [Gly14]-Humanin | MAPRGFSCLLLLTGEIDLPVKRRA |
| β-Amyloid (Human, 1-42) | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| β-Amyloid (Human, 1-28) | DAEFRHDSGYEVHHQKLVFFAEDVGSNK |
| Mitochondria-encoded Humanin [HN(M)] | MAPRGFSCLLLLTSEMDLPVK |
| Nuclear-encoded Humanin [HN(N)] (Rat) | MATRGFNCLLLSISEIDLPVKRLESPNKTRRPYGASIY |
| Colivelin | SALLRSIPAPAGASRLLLLTGEIDLP |
| ADNF-9 | SALLRSIPA |
| Abeta del-E22 | DAEFRHDSGYEVHHQKLVFFADVGSNKGAIIGLMVGGVVIA |
| [Pyr1]-Apelin-13 (Human, Bovine) | Pyr-RPRLSHKGPMPF |
| Apelin-36 (Human) | LVQPRGSRNGPGPWQGGRRKFRRQRPRLSHKGPMPF |
| Apelin-36 (Bovine) | LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF |
| Apelin-17 (Human, Bovine) | KFRRQRPRLSHKGPMPF |
| Apelin-16 (Human, Bovine) | FRRQRPRLSHKGPMPF |
| Apelin-13 (Human, Bovine) | QRPRLSHKGPMPF |
| Apelin-12 (Human, Bovine, Mouse, Rat) | RPRLSHKGPMPF |
| Apelin (23-57), Prepro(Human) | GSLMPLPDGNGLEDG NVRHLVQPRGSRNGP GPWQG-NH2 |
| Bombesin | Pyr-QRLGNQWAVGHLM-NH2 |
| [D-F6,Beta-A11,F13,Nle14]-Bombesin (6-14) | dFQWAVbAHF-Nle-NH2 |
| [D-Y6,Beta-A11,F13,Nle14]-Bombesin (6-14) | dYQWAVbAHF-Nle-NH2 |
| [Y4]-Bombesin | Pyr-QRYGNQWAVGHLM-NH2 |
| BNP-32 (Human) | SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH |
| BNP-26 (Porcine) | DSGCFGRRLDRIGSLSGLGCNVLRRY |
| BNP-32 (Rat) | NSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF |
| BNP (1-21) | HPLGSPGSASDLETS GLQEQR |
| BNP (22-46) | NHLQGKLSELQVEQTSLEPLQESPR |
| BNP (1-46) | HPLGSPGSASDLETSGLQEQRNHLQGKLSELQVEQTSLEPLQESPR |
| BNP (24-45) | EKSEEMAQRQLSKDQGPTKELL |
| β-Casomorphin-5 (Bovine) | YPFPG |
| β-Casomorphin-7 (Bovine) | YPFPGPI |
| Beta Casomorphin (1-4 Amide) (Morphiceptin) | YPFP-NH2 |
| Apamin (Honeybee, Apis mellifera) | CNCKAPETALCARRCQQH-NH2 |
| Iberiotoxin (Scorpion, Buthus tamulus) | Pyr-FTDVDCSVSKECWSVCKDLFGVDRGKCMGKKCRCYQ |
| Tertiapin (Honeybee, Apis mellifera) | ALCNCNRIIIPHMCWKKCGKK-NH2 |
| ω-Conotoxin GVIA | CKS-Hyp-GSSCS-Hyp-TSYNCCRSCN-Hyp-YTKRCY-NH2 |
| ω-Conotoxin MVIIA | CKGKGAKCSRLMYDCCTGSCRSGKC-NH2 |
| ω-Conotoxin MVIIC | CKGKGAPCRKTMYDCCSGSCGRRGKC-NH2 |
| ω-Conotoxin SVIB | CKLKGQSCRKTSYDCCSGSCGRSGKC-NH2 |
| MCD-Peptide | IKCNCKRHVIKPHICRKICGKN-NH2 |
| Palmitoyl Tripeptide | Pal-GHK |
| Palmitoyl Tetrapeptide | Pal-GQPR |
| Copper Peptide | GHK-Cu2+ |
| Acetyl Hexapeptide | Ac-EEMQRR-NH2 |
| CNP-22 (Human) | GLSKGCFGLKLDRIGSMSGLGC |
| Tyrosyl-CNP-22 (Human) | YGLSKGCFGLKLDRIGSMSGLGC |
| CNP-53 (Porcine, Rat, 1-29) | DLRVDTKSRAAWARLLHEHPNARKYKGGN |
| Dynorphin A (Human, Rat, Bovine) | YGGFLRRIRPKLKWDNQ |
| Dynorphin A (Human, 1-13) | YGGFLRRIRPKLK |
| Dynorphin | YGGFLRRQFKVVTRSQENPNTYSEDLDV |
| Dynorphin B (1-13) | YGGFLRRQFKVVT |
| Dynorphin A (Porcine, 1-8) | YGGFLRRI |
| Dynorphin A (Porcine, 1-10) | YGGFLRRIRP |
| Dynorphin A (Porcine, 1-10 Amide) | YGGFLRRIRP-NH2 |
| [D-Ala2]-Dynorphin A (Porcine, 1-11) | Y-dA-GFLRRIRPK |
| Dynorphin A (Porcine, 1-12) | YGGFLRRIRPKL |
| Dynorphin A (Porcine, 1-13 Amide) | YGGFLRRIRPKLK-NH2 |
| Dynorphin A (Porcine, 2-13) | GGFLRRIRPKLK-NH2 |
| Dynorphin A (Porcine, 2-17) | GGFLRRIRPKLKWDNQ |
| Dynorphin A (Porcine, 3-13) | GFLRRIRPKLK |
| Dynorphin A (Porcine, 6-17) | RRIRPKLKWDNQ |
| Dynorphin A (Porcine, 9-17) | RPKLKWDNQ |
| Dynorphin B / Rimorphin (Porcine) | YGGFLRRQFKVVT |
| α-Neo-Endorphin (Porcine) | YGGFLRKYPK |
| β-Neo-Endorphin (Porcine) | YGGFLRKYP |
| β-Endorphin (Human) | YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE |
| α-Endorphin / β-Lipotropin (61-76) | YGGFMTSEKSQTPLVT |
| γ-Endorphin / β-Lipotropin (61-77) | YGGFMTSEKSQTPLVTL |
| Endorphin, Ac-beta (1-16) (Human) | Ac-YGGFMTSEKSQTPLVT |
| Endorphin (1-27) Ac-Beta (Camel, Bovine, Ovine) | Ac-YGGFMTSEKSQTPLVTLFKNAIIKNAH |
| Endorphin (1-27) Beta (Camel, Bovine, Ovine) | YGGFMTSEKSQTPLVTLFKNAIIKNAH |
| Endorphin (1-27) Ac-Beta (Human) | Ac-YGGFMTSEKSQTPLVTLFKNAIIKNAY |
| Endorphin (1-26) Beta (Human) | YGGFMTSEKSQTPLVTLFKNAIIKNA |
| Endorphin (1-27) Beta (Human) | YGGFMTSEKSQTPLVTLFKNAIIKNAY |
| Endorphin (18-31) Beta (Human) | KKGE |
| Endorphin Beta (Porcine) | YGGFMTSEKSQTPLVTLFKNAIVKNAHKKGQ |
| Endorphin Beta (Rat) | YGGFMTSEKSQTPLVTLFKNAIIKNVHKKGQ |
| [D-Ala2, Met5]-Enkephalin | YdAGFM |
| [D-Ala2, Met5]-Enkephalin, Amide | YdAGFM-NH2 |
| Leucine-Enkephalin | YGGFL |
| Leucine-Enkephalin (Sulfated Form) | Y(SO₃H)-GGFL |
| Methionine-Enkephalin | YGGFM |
| [D-Ala2, D-leu5]-Enkephalin | YdA-GFdL |
| Amidorphin / Pro-Enkephalin A (104-129 Amide) (Bovine) | YGGFMKKMDELYPLEVEEEANGGEVL-NH2 |
| Leu-Enkephalin-Thr [D-Ser2] / Delta-Receptor Peptide | YdSGFLT |
| Leu-Enkephalin-Thr [D-Thr2] / DTLET | YdTGFLT |
| [Met5,Arg6]-Enkephalin | YGGFMR |
| [Met5,Arg6,Gly7,Leu8]-Enkephalin | YGGFMRGL |
| Met5,Arg6,Phe7] Enkephalin | YGGFMRF |
| [Met5,Arg6,Phe7]-Enkephalin, amide | YGGFMRF-NH2 |
| Spinorphin (Bovine) | LVVYPWT |
| Exendin-3 | HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin-4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin (5-39) | TFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin-3 (9-39 Amide) (Heloderma horridum) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Galanin (Rat) | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 |
| Galanin (Human) | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS |
| Galanin-Like Peptide (Human, 1-60) | APAHRGRGGWTLNSAGYLLGPVLHLPQMGDQDGKRETALEILDLWKAIDGLPYSHPPQPS |
| Galanin (Bovine) | GWTLNSAGYLLGPHALDSHRSFQDKHGLA-NH2 |
| Galanin (Porcine) | GWTLNSAGYLLGPHAIDNHRSFHDKYGLA-NH2 |
| Galanin (108-123), Prepro (Porcine) | LPGLPSAASSEDAGQS |
| Galanin (Porcine, Rat, 1-16) | GWTLNSAGYLLGPHAI |
| Galanin (Human, 1-19) | GWTLNSAGYLLGPHAVGNH |
| Galanin (1-30), Prepro (Human) | MARGSALLLASLLLAAALSASAGLWSPAKE |
| Galanin (89-105 Amide), Prepro (Porcine) | TIMEFLAFLHLKEAGAL-NH2 |
| Galanin (80-105, Amide), Prepro (Porcine) | LQSEDKAIRTIMEFLAFLHLKEAGAL-NH2 |
| Galanin(1-13)-P-P-(A-L)2-A-Amide, M40 | GWTLNSAGYLLGPPPALALA-NH2 |
| Galanin Like Peptide (GALP) (Human, 36-60) | ETALEILDLWKAIDGLPYSHPPQPS |
| Galanin Like Peptide (GALP) (Rat) | APAHRGRGGWTLNSAGYLLGPVLHLSSKANQGRKTDSALEILDLWKAIDGLPYSRSPRMT |
| Ghrelin (Human) | GSS(n-octanoyl)FLSPEHQRVQQRKESKKPPAKLQPR |
| [Des-Octanoyl]-Ghrelin (Human) | GSSFLSPEHQRVQQRKESKKPPAKLQPR |
| Ghrelin (Rat) | GSS(n-octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR |
| [Des-Octanoyl]-Ghrelin (Rat) | GSSFLSPEHQKAQQRKESKKPPAKLQPR |
| Ghrelin (Human, 1-14) | GSS(n-octanoyl)FLSPEHQRVQQ |
| Ghrelin (1-5 Amide) | GSS(n-octanoyl)FL-NH2 |
| [Des-Octanoyl3]-Ghrelin (1-5 Amide) | GSS(Des-octanoyl)FL-NH2 |
| Ghrelin (Human, Rat, 17-28) | ESKKPPAKLQPR |
| [Des-Octanoyl3]-Ghrelin (Rat) | GSS(DesOctanoyl)FLSPEHQKAQQRKESKKPPAKLQPR |
| Ghrelin C-terminal, Hexapeptide | AKLQPR |
| [Des-Octanoyl3]-Ghrelin (Human, 1-14) | GSS(Des-octanoyl)FLSPEHQRVQQ |
| Ghrelin (Rat, 3-28) | S(Octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR |
| [Des-Q14]-Ghrelin (Rat) | GSS(n-octanoyl)FLSPEHQKAQRKESKKPPAKLQPR |
| [Des-Octanoyl]-Ghrelin (Human, 1-18) | GSSFLSPEHQRVQQRKES |
| Ghrelin (86-117), Prepro (Human) | LSGVQYQQHSQALGKFLQDILWEEAKEAPADK |
| Ghrelin (52-85), Prepro (Human) | ALAGWLRPEDGGQAEQAEDELEVRFNAPFDVGIK |
| [Des-Octanoyl-Ser3]-Ghrelin (Human) | GSS(DesOctanoyl)FLSPEHQRVQQRKESKKPPAKLQPR |
| Ghrelin (86-117), Prepro (Rat) | LSGAQYQQHGRALGKFLQDILWEEVKEAPANK |
| Ghrelin (52-85), Prepro (Rat) | ALEGWLHPEDRGQAEEAEEELEIRFNAPFDVGIK |
| GAP (Human, 25-53) / Gn-RH Precursor (38-66) | FECTTHQPRSPLRDLKGALESLIEEETGQ |
| Peptide T | ASTTTNYT |
| Virus Replication Inhibiting Peptide | Z-dFFG |
| Fuzeon (T-20) | Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 |
| LH-RH II (Chicken) | Pyr-HWSHGWYPG-NH2 |
| LH-RH (Salmon) | Pyr-HWSYGWLPG-NH2 |
| LH-RH, Gonadoreline (Human) | Pyr-HWSYGLRPG-NH2 |
| Tunicate-3 | Pyr-HWSYEFMPG-NH2 |
| Tunicate-5 | Pyr-HWSYEYMPG-NH2 |
| Tunicate-6 | Pyr-HWSKGYSPG-NH2 |
| MCH | DFDMLRCMLGRVYRPCWQV |
| [Phe13,Tyr19]-MCH (Human, Mouse, Rat) | DFDMLRCMLGRVFRPCWQY |
| Melanin Gene Overprinted Polypeptide-14 (MGOP-14) | TIHCKWREKPLMLM |
| Melanin Gene Overprinted Polypeptide-27 (MGOP-27) (Human) | SDTCWSTTSFQKKTIHCKWREKPLMLM |
| MCH (Salmon) | DTMRCMVGRVYRPCWEV |
| Motilin (Human, Porcine) | FVPIFTYGELQRMQEKERNKGQ |
| Motilin (Canine) | FVPIFTHSELQKIREKERNKGQ |
| Neuromedin B (Human, Porcine, Rat) | GNLWATGHFM-NH2 |
| Neuromedin C | GNHWAVGHLM-NH2 |
| Neuromedin U (Rat) | YKVNEYQGPVAPSGGFFLFRPRN-NH2 |
| Neuromedin U-25 (Human) | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 |
| Neuromedin U-8 (Porcine) | YFLFRPRN-NH2 |
| Neuromedin U-25 (Porcine) | FKVDEEFQGPIVSQNRRYFLFRPRN-NH2 |
| Neuromedin U-9 (Guinea Pig) | GYFLFRPRN-NH2 |
| Neuromedin N (Porcine) | KIPYIL |
| Neuromedin S (Human) | TATWGRPFFLFRPRNGRN |
| Neuromedin S (Rat) | FFLFRPRN-NH2 |
| Neuromedin S (Mouse) | TVDFPKKDPTTSLGRPFFLFRPRN |
| Neuropeptide Y (NPY) | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
| [Leu31,Pro34]-NPY (Porcine) | YPSKPDNPGEDAPAEDLARYYSALRHYINLLTRPRY-NH2 |
| NPY (Porcine, 13-36) | PAEDLARYYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (NPY) Free Acid (Human) | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY |
| Neuropeptide Y (NPY) (Porcine) | YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (NPY) (Porcine, 2-36) | PSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (NPY) (Porcine, 16-36) | DLARYYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (NPY) (Porcine, 18-36) | ARYYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (NPY) (Porcine, 20-36) | YYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (NPY) (Porcine, 22-36) | SALRHYINLITRQRY-NH2 |
| [D-Trp32]-Neuropeptide Y (NPY) (Porcine) | YPSKPDNPGEDAPAEDLARYYSALRHYINLIdWRQRY-NH2 |
| Neuropeptide Y (NPY) (Porcine, 3-36) | SKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 |
| BAM-12P | YGGFMRRVGRPE |
| Nociceptin | FGGFTGARKSARKLANQ |
| Morphine Modulating Peptide, C-terminal Fragment | PQRF-NH2 |
| Nociceptin Antagonist | Ac-RYYRIK-NH2 |
| BAM-22P (Bovine) | YGGFMRRVGRPEWWMDYQKRYG |
| Metorphinamide (Adrenorphin) | YGGFMRRV-NH2 |
| Peptide E-3200-dalton Adrenal (Bovine) | YGGFMRRVGRPEWWMDYQKRYGGFL |
| Peptide F (Bovine) | YGGFMKKMDELYPLEVEEEANGGEVLGKRYGGFM |
| [DAla2]-Deltorphin I | YdAFDVVG-NH2 |
| Casoxin D | YVPFPPF |
| Nocistatin (Bovine) | TEPGLEEVGEIEQKQLQ |
| [Lys8]-Vasopressin | CYFQNCPKG-NH2 |
| [Arg8]-Vasopressin | CYFQNCPRG-NH2 |
| Nocistatin (Human) | MPRVRSLFQEQEEPEPGMEEAGEMEQKQLQ |
| [Arg8]-Vasotocin (Frog, Chicken) | CYIQNCPRG-NH2 |
| Diuretic Hormone (Manduca sexta) | RMPSLSIDLPMSVLRQKLSLEKERKVHALRAAANRNFLNDI-NH2 |
| Orphanin FQ (1-7) | FGGFTGA |
| Orphanin Pro FQ / Nociceptin(85-119)-Prepro / Nocistatin-35 (Human, Rat, Mouse) | MPRVRSVVQARDAEPEADAEPVADEADEVEQKQLQ |
| Orphanin Pro FQ / Nociceptin-Propro (141-157) | FSEFMRQYLVLSMQSSQ |
| Orphanin FQ / [Tyr14]-Nociceptin | FGGFTGARKSARKYANQ |
| Orphanin FQ / [Des-Phe1]-Nociceptin | GGFTGARKSARKLANQ |
| Orphanin FQ / Nociceptin (Human, Rat, Mouse, 1-11) | FGGFTGARKSA |
| Orphanin Prepro FQ / Nociceptin(85-119) /[Tyr0]-Nocistatin-35 (Rat) | YMPRVRSVVQARDAEPEADAEPVADEADEVEQKQLQ |
| Orphanin FQ / Nociceptin [Phe=Gly) -(1-13 Amide) | [Phe1gamma(CH2 -NH)-Gly2]-GFTGARKSARK-NH2 |
| Orphanin FQ (1-13 Amide) | FGGFTGARKSARK-NH2 |
| Orphanin Pro FQ (Rat, 173-181) | RTLHQNGNV |
| Orphanin Pro FQ (Rat, 154-181) / Prepro-OFQ (Mouse, 160-187 Free Acid) | FSEFMRQYLVLSMQSSQRRRTLHQNGNV |
| [Tyr0]-Nocistatin / [Tyr0]-PNP-3 (Bovine) | YTEPGLEEVGEIEQKQLQ |
| [Lys14-E-(Tyr)]-Nocistatin / [Lys14-E-(Tyr)]-PNP-3 (Bovine) | TEPGLEEVGEIEQK(Y)QLQ |
| Nocistatin-41 / PNP-3-8P (Bovine) | EIEQKQLQ |
| Nocistatin-41 / PNP-2/3 (Mouse) | MPRVRSLVQVRDAEPGADAEPGADAEPGADDAEEVEQKQLQ |
| [N-Phe1]-Orphanin FQ (1-13 Amide) | N-Benzyl-GGGFTGARKSARK-NH2 |
| [Ile3]-Pressinoic Acid | CYIQNC |
| Oxytocin | CYIQNCPLG-NH2 |
| Pancreastatin (Human, 37-52 Amide) | EEEEEMAVVPQGLFRG-NH2 |
| Xenin 25 (Human) | MLTKFETKSARVKGLSFHPKRPWIL |
| Pancreastatin (Chromograninin A (Human, 250-301 Amide)) | GESRSEALAVDGAGKPGAEEAQDPEGKGEQEHSQQKEEEEEMAVVPQGLFRG-NH2 |
| Pancreastatin (24-52) (hPST-29) (Human) | PEGKGEQEHSQQKEEEEEMAVVPQGLFRG-NH2 |
| Pancreastatin (Porcine) | GWPQAPAMDGAGKTGAEEAQPPEGKGAREHSRQEEEEETAGAPQGLFRG-NH2 |
| Pancreastatin (Porcine, 33-49) | QEEEEETAGAPQGLFRG-NH2 |
| Pancreastatin (Chromograninin A (264-314)-Amide) (Rat) | DDGQSESQAVNGKTGASEAVPSEGKGELEHSQQEEDGEEAMAGPPQGLFPG-NH2 |
| PTH-rP (Human, 7-34 Amide) | LLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 |
| PTH (Human, 1-34) | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF |
| Parathyroid Hormone (Human, 1-31 Amide) | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDV-NH2 |
| Parathyroid Hormone (Human, 1-44) | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPR |
| Parathyroid Hormone (Human, 13-34) | KHLNSMERVEWLRKKLQDVHNF |
| Parathyroid Hormone (Human, 39-68) | APLAPRDAGSQRPRKKEDNVLVESHEKSLG |
| Parathyroid Hormone (Human, 39-84) | APLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ |
| Parathyroid Hormone (Human, 69-84) | EADKADVNVLTKAKSQ |
| [Nle8,18,Tyr34]-PTH (Human, 1-34) | SVSEIQL-Nle-HNLGKHLNS-Nle-ERVEWLRKKLQDVHNY |
| [Nle8,18,Tyr34]-PTH (Human, 1-34 Amide) | SVSEIQL-Nle-HNLGKHLNS-Nle-ERVEWLRKKLQDVHNY-NH2 |
| [Nle8,18,Tyr34]-PTH (Human, 3-34 Amide) | SEIQL-Nle-HNLGKHLNS-Nle-ERVEWLRKKLQDVHNY-NH2 |
| [Tyr34]-PTH (Bovine, 1-34 Amide) | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNY-NH2 |
| [Tyr34]-PTH (Bovine, 7-34 Amide) | FMHNLGKHLSSMERVEWLRKKLQDVHNY-NH2 |
| PTH-rP (Human, 1-34 Amide) | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 |
| Parathyroid Hormone (PTH) (Bovine, 1-34) | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF |
| Parathyroid Hormone (PTH) (Human, 1-38) | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALG |
| Parathyroid Hormone (PTH)(44-68)(Human) | RDAGSQRPRKKEDNVLVESHEKSLG |
| Parathyroid Hormone-Related Protein (PTH-RP) (Human, Rat, Mouse, 1-34) | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA |
| [Tyr36]-Parathyroid Hormone-Related Protein (PTH-RP) (Chicken, 1-36 Amide) | AVSEHQLLHDKGKSIQDLRRRIFLQNLIEGVNTAEY-NH2 |
| [Tyr34]-Parathyroid Hormone-Related Protein (PTH-RP) (Human, 1-34 Amide) | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTY-NH2 |
| Parathyroid Hormone-Related Protein (PTH-RP) (Human, 1-37) | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIR |
| [Asn10.Leu11]-Parathyroid Hormone-Related Protein (PTH-RP) (Human, 7-34 Amide) | LLHNLGKSIQDLRRRFFLHHLIAEIHTA-NH2 |
| [Leu11,D-Trp12]-Parathyroid Hormone-Related Protein (PTH-RP) (Human, 7-34 Amide) | LLHDLdWKSIQDLRRRFFLHHLIAEIHTA-NH2 |
| Parathyroid Hormone-Related Protein (PTH-RP) (Human, 38-64 Amide) | ATSEVSPNSKPSPNTKNHPVRFGSDDE-NH2 |
| Parathyroid Hormone-Related Protein (PTH-RP) (Human, 67-86 Amide) | YLTQETNKVETYKEQPLKTP-NH2 |
| Parathyroid Hormone-Related Protein (PTH-RP)(107-111)(Human, Rat, Mouse) | TRSAW-NH2 |
| Parathyroid Hormone-like Peptide (PLP) (Human, 140-173) | TALLWGLKKKKENNRRTHHMQLMISLFKSPLLLL |
| TIP 39 (Tuberoinfundibular Neuropeptide) | SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
| [Cys(Acm)94]-Prokineticin 2 (PK2) (Human, 89-108) | LPGLAC(Acm)LRTSFNRFICLAQK |
| [Cys(Acm)96]-Prokineticin 1 (PK1) (Human, 81-105) | LPNLLCSRFPDGRYRC(Acm)SMDLKNINF |
| Sarafotoxin S6c | CTCNDMTDEECLNFCHQDVIW |
| Sarafotoxin S6b | CSCKDMTDKECLYFCHQDVIW |
| Urocortin (Human) | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 |
| Stresscopin (Human) | TKFTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 |
| Stresscopin-Related Peptide (Human) | HPGSRIVLSLDVPIGLLQILLEQARARAAREQATTNARILARV-NH2 |
| Urocortin (Rat) | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 |
| Urocortin II (Mouse) | VILSLDVPIGLLRILLEQARYKAARNQAATNAQILAHV-NH2 |
| Urocortin I (Mouse) | VILSLDVPIGLLRILLEQARYKAARNQAATNAQILAHVGRR-NH2 |
| Urocortin III (Mouse) | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 |
| AntiSauvagine-30 (aSvg-30) | d-FHLLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2 |
| Urotensin II (Frog) | AGNLSECFWKYCV |
| Prepro-Urotensin II (102-125) (Human) | FQDFSGQDPNILLSHLLARIWKPY |
| TRH | Pyr-HP-NH2 |
| pGlu-His-Pro-Gly-Lys-Arg | Pyr-HPGKR |
| VIP (Human, Porcine, Rat, Ovine, 10-28) | YTRLRKQMAVKKYLNSILN-NH2 |
| PHM-27 (Human) | HADGVFTSDFSKLLGQLSAKKYLESLM-NH2 |
| VIP (Human, Porcine) | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
| VIP (Human, Porcine, Rat, 1-12) | HSDAVFTDNYTR |
| VIP Antagonist | KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2 |
| [(4Cl)DPhe6,Leu17]-VIP | HSDAV-4-Cl-dFTDNYTRLRKQLAVKKYLNSILN-NH2 |
| VIP1 Agonist : [Lys15,Arg16,Leu27]-VIP (1-7)-GRF (8-27) | HSDAVFTNSYRKVLKRLSARKLLQDIL-NH2 |
| VIP1 Antagonist : [Ac-His1,D-Phe2,Lys15,Arg16,Leu27] | Ac-H-dF-DAVFTNSYRKVLKRLSARKLLQDIL-NH2 |
| VIP1 Agonist Secretin [Arg16] (Chicken) | HSDGLFTSEYSKMRGRAQVQKFIQNLM-NH2 |
| PHI-27 (Porcine) | HADGVFTSDFSRLLGQLSAKKYLESLI-NH2 |
| PHI-27 (Rat) | HADGVFTSDYSRLLGQISAKKYLESLI-NH2 |
| PHI (1-27)-Gly (Rat) | HADGVFTSDYSRLLGQISAKKYLESLIG |
| PHM-VIP Space Peptide (PHM (111-122) / Prepro VIP) | VSSNISEDPVPV |
| PHM (156-170) (Prepro VIP) | SSEGESPDFPEELEK |
